Lataa...
Treatment Outcomes of Novel Targeted Agents in Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-Analysis
Most chronic lymphocytic leukemia patients experience a relapse or become refractory to treatment with conventional chemotherapeutic agents. The network meta-analysis assesses the relative efficacy of novel targeted agents for the treatment of a relapse or refractory chronic lymphocytic leukemia. A...
Tallennettuna:
| Julkaisussa: | J Clin Med |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6572611/ https://ncbi.nlm.nih.gov/pubmed/31126075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8050737 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|